The superexacerbator phenotype in patients with COPD: a descriptive analysis

Lowie E G W Vanfleteren; Lotte M C Boonen; Martijn A Spruit; Daisy J A Janssen; Emiel F M Wouters; Frits M E Franssen

doi:10.1183/23120541.00235-2018

The superexacerbator phenotype in patients with COPD: a descriptive analysis

ERJ Open Res. 2019 Jun 4;5(2):00235-2018. doi: 10.1183/23120541.00235-2018. eCollection 2019 Apr.

Authors

Lowie E G W Vanfleteren^{1

2}, Lotte M C Boonen¹, Martijn A Spruit^{1

3

4}, Daisy J A Janssen¹, Emiel F M Wouters^{1

3}, Frits M E Franssen^{1

3}

Affiliations

¹ CIRO, Horn, The Netherlands.
² COPD Center, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
³ Dept of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.
⁴ NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.

Abstract

The superexacerbator is highly prevalent in patients with COPD entering rehabilitation and these patients have worse disease overall http://bit.ly/30q2k7M.